1. Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
   Fernanda Fortunato et al, 2021, Journal of Clinical Medicine CrossRef
2. Gene modification therapies for hereditary diseases in the fetus
   Citra N. Z. Mattar et al, 2023, Prenatal Diagnosis CrossRef
3. CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia
   Udani Gamage et al, 2023, Thalassemia Reports CrossRef
4. Lentiviral vector containing beta-globin gene for beta thalassemia gene therapy
   Maryam Abbasalipour et al, 2022, Gene Reports CrossRef
5. Thalassemia and Nanotheragnostics: Advanced Approaches for Diagnosis and Treatment
   Zahra Tariq et al, 2023, Biosensors CrossRef
6. Orofacial and Systemic Features of Thalassemia Major: Management, and Prevention with Reference to Populations in the Arabian Gulf
   Larry Z. Lockerman, 2022, CRANIO® CrossRef
7. PTD-mediated delivery of α-globin chain into Κ-562 erythroleukemia cells and α-thalassemic (HBH) patients’ RBCs ex vivo in the frame of Protein Replacement Therapy
   Androulla N. Miliotou et al, 2021, Journal of Biological Research-Thessaloniki CrossRef
8. Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology
   Lingli Li et al, 2022, Stem Cell Research & Therapy CrossRef
9. New Entity—Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement
   Mara Carsote et al, 2022, Diagnostics CrossRef
10. Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing
    Dito Anurogo et al, 2021, International Journal of Molecular Sciences CrossRef
11. Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies
    Ali T. Taher et al, 2021, Expert Review of Hematology CrossRef
12. CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma
    Maimaitili Mijiti et al, 2023, Molecular Medicine CrossRef
13. Ethical considerations of preconception and prenatal gene modification in the embryo and fetus
    Citra Nurfarah Zaini Mattar et al, 2021, Human Reproduction CrossRef
14. A New Artificial Intelligence Approach Using Extreme Learning Machine as the Potentially Effective Model to Predict and Analyze the Diagnosis of Anemia
    Dimas Chaerul Ekty Saputra et al, 2023, Healthcare CrossRef
15. Recent advances of CRISPR/Cas9 gene editing in the treatment of β-thalassemia
    Qian Xie et al, 2022, Chinese Science Bulletin CrossRef
16. A Review of CRISPR Cas9 for SCA: Treatment Strategies and Could Target β-globin Gene and BCL11A Gene using CRISPR Cas9 Prevent the Patient from Sickle Cell Anemia?
    Bambang Edi Suwito et al, 2023, Open Access Macedonian Journal of Medical Sciences CrossRef